SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors...
Bristol Myers Squibb (NYSE: BMY) today announced data from the cohorts of the Phase 1/ 2 KRYSTAL-1 study evaluating KRAZATI (adagrasib) in combination with cetuximab for the treatment of patients...
In this piece, we will take a look at the five best weight loss drug stocks to buy now. If you want to take a deeper look at the latest trends in the weight loss industry, then read 10 Best Weight...
DekaBank Deutsche Girozentrale cut its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.4% during the fourth quarter, according to the company in its most recent disclosure...
Bristol Myers Squibb (NYSE: BMY) today announced new interim results from the Phase 3 EMERGENT-4 open-label extension trial evaluating the long-term efficacy, safety and tolerability of KarXT...
Bristol Myers Squibb (NYSE: BMY) today announced interim long-term safety, tolerability and metabolic outcomes data from its Phase 3 EMERGENT program evaluating KarXT (xanomeline-trospium) in adults...
Highlander Capital Management LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 5.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor...
Bristol-Myers Squibb (NYSE:BMY - Get Free Report)'s stock price dropped 0.4% during mid-day trading on Friday . The company traded as low as $50.77 and last traded at $51.22. Approximately 2,404,170...